Kit Kit - Masu kera, masana'anta, masu ba da kaya daga China - Alishir
"An kafa shi ne a kasuwar cikin gida kuma faɗaɗa kasuwancin a waje" shine dabarun ci gaba na Kanamycin - Rationalawa - Kit,E.coli DNA Kit, Kit ɗin na E.coli DNA, Kit ɗin Kinamycin, E.Coli Residual. Kada ku taɓa yin cigaba da ƙoƙari don rashi 0% sune manyan manufofinmu biyu. Idan kuna buƙatar komai, kada ku yi shakka a tuntuɓe mu. Kamfanin yana da cikakken tsarin gudanarwa da kuma bayan - tsarin sabis. Mun sadaukar da kanmu don gina majagaba a cikin masana'antar matatar. Masana'antarmu tana shirye don ba tare da abokan ciniki daban-daban na gida da kasashen waje don samun ingantacciya da makoma mai kyau.KANAMYCIN RANAR, Gano E.Coli, E.coli hcp, E Cori HCP Elisa Kit.
GASKIYA DNA GWAMNATAR DNA GWAMNATI DA GANIN DNA Gwajin DNA yana nufin hanyoyin nazarin da aka yi amfani da su don samfuran bipharmaceuthaces bayan masana'antu. Wannan ty
Gabatarwa: Youngiyyar kwayar cutar HIV ganewar cuta ta juyo na gano asalin binciken likitanci, sashen ganowa na kwayar cutar kanjamau ya ga ci gaba mai mahimmanci. Daga cikin waɗannan, ci gaba da aikace-aikacen sababbin abubuwa a cikin P24 Elisa Kits suna da E
Gabatarwa ga E.Coli RNA Gano 'yan kwanannan, ci gaba a ilimin kwayar halitta sun nuna mahimmancin rawar da gano RNA da aikace-aikace masana'antu. Gano da Qualictification na Essiherichia Cani RNA
Daga 4 ga watan Agusta zuwa 5th zuwa 5th, 6th Ba'amuruwan hadin gwiwar Biomasedical biodial da 20222 na kasar Sin ke gudanar da bikin karbar bakaken bikin Suzhou Jinji Lake Kingin Suzhou Jinji Lake Kingin Suzhou Jinji Lake Ketmpins. Taron ya yi tsawon kwanaki 2 kuma ya aiwatar da 12 na musamman
Gabatarwa zuwa Gano DNA ta E.Coli Ruwa mai mahimmanci ● Mai mahimmanci a cikin ilimin halittar ilimin halittu, Gano Residims na DNA, musamman e.coli Rational DNA, ya fito a matsayin m damuwa. Kamar yadda injiniyan kwayoyin halitta da biopharmacetic
A cikin Maris 18 - 19, 2023, babban taron masana'antu na Amurka 8 na shekara 8 ya faru ne a cibiyar Expso Expso Expso. A yayin taron, "2022 an sanar da masu samar da kayayyakin" an sanar da masu lashe gasar, tare da Bipharma reopharma da "2022 EB
Samari iri iri ne cikakke, inganci mai tsada, isarwa yana da sauri da sufuri shine tsaro, yana da kyau, muna farin cikin yin aiki tare da kamfanin da aka sani!
Kyakkyawan inganci da isarwa mai sauri, yana da kyau sosai. Wasu samfura suna da matsala kaɗan, amma mai ba da tallafi ya maye gurbinsu lokaci, gaba ɗaya, mun gamsu.
Wannan kamfanin yana da ra'ayin "inganci mafi kyau, farashin sarrafawa, farashin aiki sun fi dacewa", saboda haka suna da dalilin da muke buƙata don yin aiki tare.
Koyaushe mun yi imani da cewa cikakkun bayanai sun yanke shawarar ingancin samfurin kamfanin, a cikin wannan girmamawa, kamfanin ya tabbatar da bukatunmu da kayanmu suna haɗuwa da tsammaninmu.
Masallan suna da kayan aiki na ci gaba, da ƙwararrun ma'aikatan da matakin kulawa mai kyau, don haka ingancin samfuri yana da tabbacin, wannan haɗin yana da annashuwa da farin ciki!